Peroxisome Proliferator Activated Receptor Delta Market Report

Europe Peroxisome Proliferator Activated Receptor Delta Market Size, Status and Forecast 2014-2026

  • POSTDATE：Feb 04, 2020
  • PAGES：202
  • REPORT CODE：GMM459909
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Peroxisome Proliferator Activated Receptor Delta market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Peroxisome Proliferator Activated Receptor Delta Market Segmentations:

    By Player:

    • T3D Therapeutics Inc

    • Chipscreen Biosciences Ltd

    • Senju Pharmaceutical Co Ltd

    • Inventiva

    • Connexios Life Sciences Pvt Ltd

    • CymaBay Therapeutics Inc

    • Nippon Chemiphar Co Ltd

    • Mitobridge Inc

    • Genfit SA

    By Type:

    • MTB-2

    • HPP-593

    • CNX-013B2

    • CS-038

    • MA-0204

    • Others

    By End-User:

    • Bone Disorders

    • Colitis

    • Obesity

    • Osteoporosis

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Peroxisome Proliferator Activated Receptor Delta Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of MTB-2 from 2014 to 2026

    • 1.3.2 Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of HPP-593 from 2014 to 2026

    • 1.3.3 Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of CNX-013B2 from 2014 to 2026

    • 1.3.4 Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of CS-038 from 2014 to 2026

    • 1.3.5 Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of MA-0204 from 2014 to 2026

    • 1.3.6 Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of Bone Disorders from 2014 to 2026

    • 1.4.2 Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of Colitis from 2014 to 2026

    • 1.4.3 Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of Obesity from 2014 to 2026

    • 1.4.4 Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of Osteoporosis from 2014 to 2026

    • 1.4.5 Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Peroxisome Proliferator Activated Receptor Delta Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Peroxisome Proliferator Activated Receptor Delta by Major Types

      • 3.4.1 Market Size and Growth Rate of MTB-2

      • 3.4.2 Market Size and Growth Rate of HPP-593

      • 3.4.3 Market Size and Growth Rate of CNX-013B2

      • 3.4.4 Market Size and Growth Rate of CS-038

      • 3.4.5 Market Size and Growth Rate of MA-0204

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Peroxisome Proliferator Activated Receptor Delta Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Peroxisome Proliferator Activated Receptor Delta by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Peroxisome Proliferator Activated Receptor Delta for Bone Disorders

      • 4.4.2 Market Size and Growth Rate of Peroxisome Proliferator Activated Receptor Delta for Colitis

      • 4.4.3 Market Size and Growth Rate of Peroxisome Proliferator Activated Receptor Delta for Obesity

      • 4.4.4 Market Size and Growth Rate of Peroxisome Proliferator Activated Receptor Delta for Osteoporosis

      • 4.4.5 Market Size and Growth Rate of Peroxisome Proliferator Activated Receptor Delta for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Peroxisome Proliferator Activated Receptor Delta Production Analysis by Top Regions

    • 5.2 Europe Peroxisome Proliferator Activated Receptor Delta Consumption Analysis by Top Regions

    • 5.3 Europe Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

      • 5.3.3 France Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

    6 Product Circulation of Peroxisome Proliferator Activated Receptor Delta Market among Top Countries

    • 6.1 Top 5 Export Countries in Peroxisome Proliferator Activated Receptor Delta Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Peroxisome Proliferator Activated Receptor Delta Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Peroxisome Proliferator Activated Receptor Delta Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Peroxisome Proliferator Activated Receptor Delta Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Peroxisome Proliferator Activated Receptor Delta Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Peroxisome Proliferator Activated Receptor Delta Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Peroxisome Proliferator Activated Receptor Delta Landscape Analysis

    • 7.1 Germany Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major Types

    • 7.2 Germany Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major End-Users

    8. UK Peroxisome Proliferator Activated Receptor Delta Landscape Analysis

    • 8.1 UK Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major Types

    • 8.2 UK Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major End-Users

    9. France Peroxisome Proliferator Activated Receptor Delta Landscape Analysis

    • 9.1 France Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major Types

    • 9.2 France Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major End-Users

    10. Italy Peroxisome Proliferator Activated Receptor Delta Landscape Analysis

    • 10.1 Italy Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major Types

    • 10.2 Italy Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major End-Users

    11. Spain Peroxisome Proliferator Activated Receptor Delta Landscape Analysis

    • 11.1 Spain Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major Types

    • 11.2 Spain Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major End-Users

    12. Poland Peroxisome Proliferator Activated Receptor Delta Landscape Analysis

    • 12.1 Poland Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major Types

    • 12.2 Poland Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major End-Users

    13. Russia Peroxisome Proliferator Activated Receptor Delta Landscape Analysis

    • 13.1 Russia Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major Types

    • 13.2 Russia Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major End-Users

    14. Switzerland Peroxisome Proliferator Activated Receptor Delta Landscape Analysis

    • 14.1 Switzerland Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major Types

    • 14.2 Switzerland Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major End-Users

    15. Turkey Peroxisome Proliferator Activated Receptor Delta Landscape Analysis

    • 15.1 Turkey Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major Types

    • 15.2 Turkey Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peroxisome Proliferator Activated Receptor Delta Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Top Countries

      • 16.3.1 Denmark Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate

      • 16.3.2 Finland Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate

      • 16.3.3 Norway Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate

      • 16.3.4 Sweden Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate

      • 16.3.6 Iceland Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Peroxisome Proliferator Activated Receptor Delta Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Top Countries

      • 17.3.1 Belgium Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate

      • 17.3.2 Netherlands Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate

      • 17.3.3 Luxembourg Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Peroxisome Proliferator Activated Receptor Delta Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Peroxisome Proliferator Activated Receptor Delta Landscape Analysis by Top Countries

      • 18.3.1 Estonia Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate

      • 18.3.2 Latvia Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate

      • 18.3.3 Lithuania Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 T3D Therapeutics Inc

      • 19.1.1 T3D Therapeutics Inc Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Chipscreen Biosciences Ltd

      • 19.2.1 Chipscreen Biosciences Ltd Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Senju Pharmaceutical Co Ltd

      • 19.3.1 Senju Pharmaceutical Co Ltd Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Inventiva

      • 19.4.1 Inventiva Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Connexios Life Sciences Pvt Ltd

      • 19.5.1 Connexios Life Sciences Pvt Ltd Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 CymaBay Therapeutics Inc

      • 19.6.1 CymaBay Therapeutics Inc Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Nippon Chemiphar Co Ltd

      • 19.7.1 Nippon Chemiphar Co Ltd Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Mitobridge Inc

      • 19.8.1 Mitobridge Inc Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Genfit SA

      • 19.9.1 Genfit SA Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    The List of Tables and Figures (Totals 101 Figures and 138 Tables)

    • Figure Product Picture

    • Figure Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of MTB-2 from 2014 to 2026

    • Figure Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of HPP-593 from 2014 to 2026

    • Figure Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of CNX-013B2 from 2014 to 2026

    • Figure Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of CS-038 from 2014 to 2026

    • Figure Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of MA-0204 from 2014 to 2026

    • Figure Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of Bone Disorders from 2014 to 2026

    • Figure Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of Colitis from 2014 to 2026

    • Figure Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of Obesity from 2014 to 2026

    • Figure Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of Osteoporosis from 2014 to 2026

    • Figure Europe Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure UK Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure France Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Peroxisome Proliferator Activated Receptor Delta Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Peroxisome Proliferator Activated Receptor Delta Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Peroxisome Proliferator Activated Receptor Delta

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Peroxisome Proliferator Activated Receptor Delta by Different Types from 2014 to 2026

    • Table Consumption Share of Peroxisome Proliferator Activated Receptor Delta by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of MTB-2

    • Figure Market Size and Growth Rate of HPP-593

    • Figure Market Size and Growth Rate of CNX-013B2

    • Figure Market Size and Growth Rate of CS-038

    • Figure Market Size and Growth Rate of MA-0204

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Peroxisome Proliferator Activated Receptor Delta by Different End-Users from 2014 to 2026

    • Table Consumption Share of Peroxisome Proliferator Activated Receptor Delta by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Bone Disorders

    • Figure Market Size and Growth Rate of Colitis

    • Figure Market Size and Growth Rate of Obesity

    • Figure Market Size and Growth Rate of Osteoporosis

    • Figure Market Size and Growth Rate of Others

    • Table Europe Peroxisome Proliferator Activated Receptor Delta Production by Major Regions

    • Table Europe Peroxisome Proliferator Activated Receptor Delta Production Share by Major Regions

    • Figure Europe Peroxisome Proliferator Activated Receptor Delta Production Share by Major Countries and Regions in 2014

    • Table Europe Peroxisome Proliferator Activated Receptor Delta Consumption by Major Regions

    • Table Europe Peroxisome Proliferator Activated Receptor Delta Consumption Share by Major Regions

    • Table Germany Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

    • Table UK Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

    • Table France Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

    • Table Italy Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

    • Table Spain Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

    • Table Poland Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

    • Table Russia Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

    • Table Switzerland Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

    • Table Turkey Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peroxisome Proliferator Activated Receptor Delta Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Peroxisome Proliferator Activated Receptor Delta Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Peroxisome Proliferator Activated Receptor Delta Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Peroxisome Proliferator Activated Receptor Delta Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Peroxisome Proliferator Activated Receptor Delta Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Peroxisome Proliferator Activated Receptor Delta Consumption by Types from 2014 to 2026

    • Table Germany Peroxisome Proliferator Activated Receptor Delta Consumption Share by Types from 2014 to 2026

    • Table Germany Peroxisome Proliferator Activated Receptor Delta Consumption by End-Users from 2014 to 2026

    • Table Germany Peroxisome Proliferator Activated Receptor Delta Consumption Share by End-Users from 2014 to 2026

    • Table UK Peroxisome Proliferator Activated Receptor Delta Consumption by Types from 2014 to 2026

    • Table UK Peroxisome Proliferator Activated Receptor Delta Consumption Share by Types from 2014 to 2026

    • Table UK Peroxisome Proliferator Activated Receptor Delta Consumption by End-Users from 2014 to 2026

    • Table UK Peroxisome Proliferator Activated Receptor Delta Consumption Share by End-Users from 2014 to 2026

    • Table France Peroxisome Proliferator Activated Receptor Delta Consumption by Types from 2014 to 2026

    • Table France Peroxisome Proliferator Activated Receptor Delta Consumption Share by Types from 2014 to 2026

    • Table France Peroxisome Proliferator Activated Receptor Delta Consumption by End-Users from 2014 to 2026

    • Table France Peroxisome Proliferator Activated Receptor Delta Consumption Share by End-Users from 2014 to 2026

    • Table Italy Peroxisome Proliferator Activated Receptor Delta Consumption by Types from 2014 to 2026

    • Table Italy Peroxisome Proliferator Activated Receptor Delta Consumption Share by Types from 2014 to 2026

    • Table Italy Peroxisome Proliferator Activated Receptor Delta Consumption by End-Users from 2014 to 2026

    • Table Italy Peroxisome Proliferator Activated Receptor Delta Consumption Share by End-Users from 2014 to 2026

    • Table Spain Peroxisome Proliferator Activated Receptor Delta Consumption by Types from 2014 to 2026

    • Table Spain Peroxisome Proliferator Activated Receptor Delta Consumption Share by Types from 2014 to 2026

    • Table Spain Peroxisome Proliferator Activated Receptor Delta Consumption by End-Users from 2014 to 2026

    • Table Spain Peroxisome Proliferator Activated Receptor Delta Consumption Share by End-Users from 2014 to 2026

    • Table Poland Peroxisome Proliferator Activated Receptor Delta Consumption by Types from 2014 to 2026

    • Table Poland Peroxisome Proliferator Activated Receptor Delta Consumption Share by Types from 2014 to 2026

    • Table Poland Peroxisome Proliferator Activated Receptor Delta Consumption by End-Users from 2014 to 2026

    • Table Poland Peroxisome Proliferator Activated Receptor Delta Consumption Share by End-Users from 2014 to 2026

    • Table Russia Peroxisome Proliferator Activated Receptor Delta Consumption by Types from 2014 to 2026

    • Table Russia Peroxisome Proliferator Activated Receptor Delta Consumption Share by Types from 2014 to 2026

    • Table Russia Peroxisome Proliferator Activated Receptor Delta Consumption by End-Users from 2014 to 2026

    • Table Russia Peroxisome Proliferator Activated Receptor Delta Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Peroxisome Proliferator Activated Receptor Delta Consumption by Types from 2014 to 2026

    • Table Switzerland Peroxisome Proliferator Activated Receptor Delta Consumption Share by Types from 2014 to 2026

    • Table Switzerland Peroxisome Proliferator Activated Receptor Delta Consumption by End-Users from 2014 to 2026

    • Table Switzerland Peroxisome Proliferator Activated Receptor Delta Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Peroxisome Proliferator Activated Receptor Delta Consumption by Types from 2014 to 2026

    • Table Turkey Peroxisome Proliferator Activated Receptor Delta Consumption Share by Types from 2014 to 2026

    • Table Turkey Peroxisome Proliferator Activated Receptor Delta Consumption by End-Users from 2014 to 2026

    • Table Turkey Peroxisome Proliferator Activated Receptor Delta Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peroxisome Proliferator Activated Receptor Delta Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peroxisome Proliferator Activated Receptor Delta Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peroxisome Proliferator Activated Receptor Delta Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peroxisome Proliferator Activated Receptor Delta Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peroxisome Proliferator Activated Receptor Delta Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peroxisome Proliferator Activated Receptor Delta Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peroxisome Proliferator Activated Receptor Delta Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peroxisome Proliferator Activated Receptor Delta Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peroxisome Proliferator Activated Receptor Delta Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peroxisome Proliferator Activated Receptor Delta Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peroxisome Proliferator Activated Receptor Delta Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peroxisome Proliferator Activated Receptor Delta Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peroxisome Proliferator Activated Receptor Delta Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peroxisome Proliferator Activated Receptor Delta Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peroxisome Proliferator Activated Receptor Delta Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peroxisome Proliferator Activated Receptor Delta Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peroxisome Proliferator Activated Receptor Delta Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peroxisome Proliferator Activated Receptor Delta Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Peroxisome Proliferator Activated Receptor Delta Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of T3D Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of T3D Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of T3D Therapeutics Inc

    • Figure Revenue and Market Share Analysis of T3D Therapeutics Inc

    • Table Product and Service Introduction of T3D Therapeutics Inc

    • Table Company Profile and Development Status of Chipscreen Biosciences Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chipscreen Biosciences Ltd

    • Figure Sales and Growth Rate Analysis of Chipscreen Biosciences Ltd

    • Figure Revenue and Market Share Analysis of Chipscreen Biosciences Ltd

    • Table Product and Service Introduction of Chipscreen Biosciences Ltd

    • Table Company Profile and Development Status of Senju Pharmaceutical Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Senju Pharmaceutical Co Ltd

    • Figure Sales and Growth Rate Analysis of Senju Pharmaceutical Co Ltd

    • Figure Revenue and Market Share Analysis of Senju Pharmaceutical Co Ltd

    • Table Product and Service Introduction of Senju Pharmaceutical Co Ltd

    • Table Company Profile and Development Status of Inventiva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Inventiva

    • Figure Sales and Growth Rate Analysis of Inventiva

    • Figure Revenue and Market Share Analysis of Inventiva

    • Table Product and Service Introduction of Inventiva

    • Table Company Profile and Development Status of Connexios Life Sciences Pvt Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Connexios Life Sciences Pvt Ltd

    • Figure Sales and Growth Rate Analysis of Connexios Life Sciences Pvt Ltd

    • Figure Revenue and Market Share Analysis of Connexios Life Sciences Pvt Ltd

    • Table Product and Service Introduction of Connexios Life Sciences Pvt Ltd

    • Table Company Profile and Development Status of CymaBay Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CymaBay Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of CymaBay Therapeutics Inc

    • Figure Revenue and Market Share Analysis of CymaBay Therapeutics Inc

    • Table Product and Service Introduction of CymaBay Therapeutics Inc

    • Table Company Profile and Development Status of Nippon Chemiphar Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nippon Chemiphar Co Ltd

    • Figure Sales and Growth Rate Analysis of Nippon Chemiphar Co Ltd

    • Figure Revenue and Market Share Analysis of Nippon Chemiphar Co Ltd

    • Table Product and Service Introduction of Nippon Chemiphar Co Ltd

    • Table Company Profile and Development Status of Mitobridge Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitobridge Inc

    • Figure Sales and Growth Rate Analysis of Mitobridge Inc

    • Figure Revenue and Market Share Analysis of Mitobridge Inc

    • Table Product and Service Introduction of Mitobridge Inc

    • Table Company Profile and Development Status of Genfit SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genfit SA

    • Figure Sales and Growth Rate Analysis of Genfit SA

    • Figure Revenue and Market Share Analysis of Genfit SA

    • Table Product and Service Introduction of Genfit SA

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US